Has Pharma Money Influenced Your Doctor?
How Industry Dollars Reached Your Doctors
By Mike Tigas, Ryann Grochowski Jones, Charles Ornstein, and Lena Groeger, ProPublica. Updated October 17, 2019
Pharmaceutical and medical device companies are required by law to release details of their payments to a variety of doctors and U.S. teaching hospitals for promotional talks, research and consulting, among other categories. Use this tool to search for general payments (excluding research and ownership interests) made from August 2013 to December 2018. | About the Dollars for Docs Data → | Read the entire series →
Pharma Money Reaches Guideline Writers, Patient Groups, Even Doctors on Twitter
How Industry Money Reaches Physicians
by Charles Ornstein
Jan. 17, 2017
“The very way we all think about disease — and the best ways to research, define, prevent, and treat it — is being subtly distorted because so many of the ostensibly independent players, including patient advocacy groups, are largely singing tunes acceptable to companies seeking to maximize markets for drugs and devices,” researchers Ray Moynihan and Lisa Bero wrote in an accompanying commentary.
“More than two-thirds of patient advocacy organizations that responded to a survey indicated that they had received industry funding in their last fiscal year. For most, the money represented a small share of their budget. But 12 percent said they received more than half of their money from industry.”